Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1542/neo.22-1-e61 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Diagnosis and treatment recommendations for glucose transporter 1 deficiency syndrome.
World J Pediatr
January 2025
The First Hospital of Peking University, Beijing, China.
Background: Glucose transporter 1 deficiency syndrome (Glut1DS) was initially reported by De Vivo and colleagues in 1991. This disease arises from mutations in the SLC2A1 and presents with a broad clinical spectrum. It is a treatable neuro-metabolic condition, where prompt diagnosis and initiation of ketogenic dietary therapy can markedly enhance the prognosis.
View Article and Find Full Text PDFGeneralized Seizure as an Acute post-Lu177-DOTATATE Side Effect in a Case of Recurrent Meningioma.
Cancer Biother Radiopharm
January 2025
Department of Nuclear Medicine, Namazi Hospital, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
[Lu]Lu-DOTATATE is a newly trending acceptable therapy in recurrent/residual meningioma with good safety. However, recognizing any possible side effects in this special population would be helpful for better management and individualization of this useful treatment. Although the seizure has been previously reported in a few cases after [Lu]Lu-DOTATATE therapy in recurrent meningioma, the acute onset of seizure in these patients, early after therapeutic radioligand administration, is not reported to the best of our knowledge.
View Article and Find Full Text PDFAcute Encephalopathy With Biphasic Seizures and Late Reduced Diffusion in a Child With Severe Coronavirus Disease 2019.
Pediatr Neurol
December 2024
Department of Radiology, Lucile Packard Children's Hospital, Stanford University School of Medicine, Stanford, California.
Development of a rapid screener to elicit patient preferences for antiseizure medication discontinuation.
Epilepsy Behav
December 2024
University of Michigan, Department of Neurology, Ann Arbor, MI, USA. Electronic address:
Objective: While guidelines encourage individualized discussions of the risks and benefits of antiseizure medication (ASM) withdrawal after a period of seizure-freedom, no formal methods exist for assessing patient preferences. We report the initial development of a rapid patient preferences screener.
Methods: We conducted a mixed-methods study of adults who were ≥1 year seizure-free and seen for epilepsy across three institutions.
Improving the health literacy of persons with epilepsy.
Epilepsy Behav
December 2024
Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address:
Improving health literacy can improve health. This essay reviews the resources available to help improve epilepsy health literacy, including websites, drug inserts/labels/information leaflets, patient educators, handouts, plain language, lay summaries, and other efforts to close the gaps between research and epilepsy health literacy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!